Dr. Anna Baran, KCR Chief Medical Officer Last week’s press release from the Health and Food Safety Department of the European Commission reignites hope for a new path towards regulating the European pharmaceutical market but also to addressing vital public health challenges. Some of the key messages from the release…

We understand the challenges and we have the solutions. Curandus connects you to patients and sites ensuring true integration and precisely tailored solutions. Decentralized clinical trials are well-known for their ability to reduce the burden on patients and sites while maintaining clinical trial efficiency and integrity. KCR’s Curandus offering…

Doug Bain, KCR Chief Technology Officer At KCR, we are often required to work with multiple systems to support the clinical trials we run. Maintaining efficient and effective connections between these systems — both from an operational and archiving perspective — is critical for ourselves and our sponsors. One of…

Doug Bain, KCR Chief Technology Officer The Association for Clinical Data Management (ACDM) hosted their annual conference in Barcelona from 12–14 March 2023. This year’s gathering was one of the most informative and inspiring conferences that I have attended for some time. Clinical Data Managers are often some of the…

Celebrated annually on March 8th, International Women’s Day is a global day of recognition to celebrate the achievements of women and to call for equality and the advancement of women worldwide. KCR is proud to uplift the voices and achievements of women across the globe, especially here, where they make…

Aneta Szewczyk, Head of Clinical Operations, KCR Placement Q: What’s the difference between FSP and FSP+? A: We are excited to shed light on the distinction between Functional Service Provision (FSP) and its advanced counterpart, FSP+. At KCR, we believe in providing valuable insights to our esteemed LinkedIn community. FSP…

Dr. Anna Baran, KCR Chief Medical Officer Rare Disease Day is a globally coordinated movement to shed light on rare diseases, to commit to working towards health equity, and to enhance access to diagnosis and therapies for people living with a rare disease.[1] The role the pharmaceutical industry plays in…

KCR Chief Technology Officer, Doug Bain, joined a panel of technology experts on Thursday’s ACDM Hot Topic Panel. The focus of this panel was the question, “What’s next for EDC?” In addition to KCR, the panel included voices from vendors and Sponsors who covered a variety of topics in the…

KCR experts are always on the lookout for top trends, but a new calendar year brings a lot of new opportunity. KCR thought leaders are surveying their sectors and weighing in on what they expect from the clinical research industry in 2023.